Clinical Research Division, Fred Hutch
Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.
Assistant Professor, Oncology
University of Washington School of Medicine
M.D., Temple University School of Medicine, 2008
B.S., Chemical Engineering, University of Delaware, 2004
Translational prostate cancer research
Novel therapeutics/drug development
Study Number: 9984
Study Number: RG1005038
Study Number: 20181583
Study Number: RG1004978
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210.